When attending a botulinum toxin appointment, patients should inform their practitioner that they are taking Ozempic, including details about: The dose and duration of Ozempic treatment Any recent dose changes or titration schedule Current side effects, particularly nausea, vomiting, or gastrointestinal symptoms Whether weight loss has occurred and the approximate amount Use of insulin or sulfonylureas, as these combined with Ozempic increase hypoglycaemia risk [1] [2] Any history of diabetic retinopathy or current ophthalmology care Any other medications, including over-the-counter products and supplements Pregnancy status or plans to conceive (semaglutide is contraindicated in pregnancy and should be discontinued at least 2 months before planned conception) [1] [2] Similarly, when discussing Ozempic with a GP or diabetes specialist, patients should mention if they receive regular botulinum toxin treatments

Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase [PMID: 8339559] Laboratory literature summary: Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione S-transferase in pathologic corneas
1 Introduction The global burden of steatotic liver disease (SLD), also known as fatty liver disease, is undergoing a profound epidemiological shift
Alternating dose protocols do not prevent MC1R receptor downregulation or extend effective cycle length beyond 12 weeks
When refrigeration is needed, travellers can: request a mini fridge from the hotel use a portable medication cooler keep medication in an insulated pouch with cooling packs Most hotels are familiar with requests for medication storage and are usually happy to assist
Retatrutide, like all GLP-1 receptor agonists, carries a warning about medullary thyroid carcinoma (MTC)